A Randomized Clinical Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss due to R
Research Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Jaeb Center For Health Research
Start Date
October 16, 2025
End Date
December 31, 2028
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Jaeb Center For Health Research
Start Date
October 16, 2025
End Date
December 31, 2028